Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Discordance Between Patient and Physician Global Assessments in Early Systemic Sclerosis.
Journal: Arthritis care & research
Published: November 21, 2025
Association of Type III and Type VI Collagen Neoepitopes With Disease Severity in Systemic Sclerosis.
Journal: The Journal of rheumatology
Published: November 05, 2025
Dense fine speckled antinuclear antibody patterns: Clinical correlations and implications.
Journal: Current rheumatology research
Published: August 13, 2025
Use of Nintedanib for the Treatment of Systemic Sclerosis-associated Interstitial Lung Disease at Expert Scleroderma Centers in the United States.
Journal: Annals of the American Thoracic Society
Published: April 10, 2025
Psychometric Evaluation of the Scleroderma Skin Questionnaire: A Novel Patient-Reported Outcome for Skin Disease in Patients With Systemic Sclerosis.
Journal: The Journal of rheumatology
Published: December 09, 2024
Hand Swelling and Other Non-Raynaud Phenomenon Symptoms as the Initial Presentation of Systemic Sclerosis: Prevalence and Clinical Associations in Two US Cohorts.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: October 09, 2024
An Experimental Phototherapy Device for Studying the Effects of Blue Light on Patients with Raynaud's Phenomenon.
Journal: Annals of biomedical engineering
Published: October 25, 2023
The primary cardiomyopathy of systemic sclerosis on cardiovascular magnetic resonance imaging.
Journal: European heart journal. Cardiovascular Imaging
Published: March 21, 2023
CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilization.
Journal: Rheumatology (Oxford, England)
Published: February 02, 2023
Qualitative Interviews to Assess the Content Validity and Usability of the Electronic Raynaud Diary in Patients with Systemic Sclerosis.
Journal: ACR open rheumatology
Published: March 30, 2022
Safety and efficacy of abatacept in early diffuse cutaneous systemic sclerosis (ASSET): open-label extension of a phase 2, double-blind randomised trial.
Journal: The Lancet. Rheumatology
Published: December 30, 2021
Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis-associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled Trial.
Journal: American journal of respiratory and critical care medicine
Published: March 02, 2021
Last Updated: 09/26/2026